Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SS Innovations International (SSII) Cash & Equivalents (2016 - 2026)

SS Innovations International's Cash & Equivalents history spans 5 years, with the latest figure at $3.2 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 587.33% to $3.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.2 million, a 587.33% increase, with the full-year FY2025 number at $3.2 million, up 587.33% from a year prior.
  • Cash & Equivalents hit $3.2 million in Q4 2025 for SS Innovations International, down from $5.7 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for SSII hit a ceiling of $15.9 million in Q1 2025 and a floor of $217177.0 in Q4 2022.
  • Historically, Cash & Equivalents has averaged $2.9 million across 5 years, with a median of $514143.0 in 2022.
  • Biggest five-year swings in Cash & Equivalents: plummeted 96.66% in 2024 and later skyrocketed 2478.39% in 2025.
  • Tracing SSII's Cash & Equivalents over 5 years: stood at $405774.0 in 2021, then crashed by 46.48% to $217177.0 in 2022, then soared by 831.16% to $2.0 million in 2023, then plummeted by 76.93% to $466500.0 in 2024, then soared by 587.33% to $3.2 million in 2025.
  • Business Quant data shows Cash & Equivalents for SSII at $3.2 million in Q4 2025, $5.7 million in Q3 2025, and $11.4 million in Q2 2025.